“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
EPA sues Oklahoma utility for failing to estimate emissions that did not occur
Illinois Cops: Don't Legalize Weed, Or We'll Have to Kill Our Drug Dogs
Peter King calls for “increased surveillance” of Muslims after Boston
Trump Betrays Trumpism: Syria in the Crosshairs
San Antonio Police Leave Man Paralyzed for Taking Photos of Wife’s Business
NYPD: Largest-ever gun seizure by an undercover cop was thanks to ‘stop and frisk’
How Snowden Did an End Run Around the NSA and the Obama Administration
Pirate Party Prompts Successful Campaign Finance Ruling for Bitcoin
New Hampshire Town Sues Over Meter Feeding
Mobile Apps Bringing a Taste of the Free Market to China
Tax Haven: Russia
Why is Putin stockpiling gold?
Samsung phones spontaneously text users’ photos to random contacts
How Dare the Iranians Elect a Moderate!
Chicago Commissioner Pleads With UN To Deploy Foreign Troops In US